CAPS vs EW · rev $45.8M vs P/E 47, rev $1.39B
Capstone Holding Corp. Common Stock (CAPS) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Capstone Holding Corp. Common Stock (CAPS) is a building materials company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CAPS revenue for 2024-12-31 was $45.8M. Net income was -$2.6M. Revenue was down 5.8% from 2023-12-31 to 2024-12-31. CAPS currently screens at market cap $3.7M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CAPS currently screens at market cap $3.7M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CAPS and EW stock pages for the full models.
Not investment advice.